Topics

Head Of PhRMA Says It Would Be Mistake To Think Pelosi’s Aggressive Drug Pricing Bill Won’t Become Reality

08:37 EDT 11 Oct 2019 | Kaiser Health News

Pharmaceutical Research and Manufacturers of America CEO Steve Ubl is treating House Speaker Nancy Pelosi's drug pricing bill like a threat despite doubts that it could make it through the GOP-controlled Senate. “We would like to see a balanced package emerge from the legislative process this year and we’re working both sides of the aisle towards that end," Ubl said.

Original Article: Head Of PhRMA Says It Would Be Mistake To Think Pelosi’s Aggressive Drug Pricing Bill Won’t Become Reality

NEXT ARTICLE

More From BioPortfolio on "Head Of PhRMA Says It Would Be Mistake To Think Pelosi’s Aggressive Drug Pricing Bill Won’t Become Reality"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...